Physician profile
Robert Rao
NPI 1437114485
$2,792.80
in general payments reported to CMS, 2019-2025
33 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $65.36 · 2021: $26.56 · 2022: $47.82 · 2023: $568 · 2024: $417 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,543 · Travel and Lodging: $498 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,543.27 |
| Travel and Lodging | $497.97 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $988.75 | 2022-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $286.88 | 2023-2024 | Echelon Circular, Echelon Flex, Echelon; Endopath |
| Csl Behring | $177.99 | 2019-2024 | Kcentra |
| W. L. Gore & Associates, INC. | $144.58 | 2019 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Boston Scientific Corporation | $95.71 | 2024 | Rezum Generator |
| Kerecis Limited | $95.61 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Genentech USA, INC. | $91.57 | 2019 | |
| Smith+Nephew, INC. | $73.72 | 2019-2024 | Oasis, Stravix Pl |
| Trevena, INC. | $71.64 | 2023-2024 | Olinvyk |
| Davol INC. | $70.52 | 2022-2025 | Arista, Phasix Mesh |
| Hologic Sales and Service, LLC | $66.99 | 2024-2025 | Trunode, Magtrace |
| Dilon Technologies, INC. | $46.67 | 2023 | Hemoblast Bellows |
| Merck Sharp & Dohme LLC | $43.26 | 2023-2025 | Keytruda, Lynparza |
| Olympus America INC. | $41.82 | 2019-2023 | Itind System, Soltive |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $29.89 | 2024 | Artegraft Vascular Graft |
| Dendreon Pharmaceuticals LLC | $28.47 | 2020 | |
| Tei Biosciences INC | $27.52 | 2019 | |
| Becton, Dickinson and Company | $27.25 | 2019 | |
| Endogastric Solutions, INC | $25.16 | 2019 | |
| Sirius Medical Systems | $24.50 | 2024 | Pintuition |
| Medtronic, INC. | $24.29 | 2025 | Dextile |
| E.R. Squibb & Sons, L.L.C. | $23.64 | 2019 | |
| Endo USA, INC. | $22.44 | 2025 | Xiaflex |
| Takeda Pharmaceuticals U.S.A., INC. | $21.78 | 2024 | Gattex |
| Bayer Healthcare Pharmaceuticals INC. | $18.57 | 2019 | |
| Monaghan Medical Corporation | $17.05 | 2023 | Aerochamber |
| Conmed Corporation | $15.86 | 2024 | Airseal |
| Vertex Pharmaceuticals Incorporated | $15.58 | 2024 | |
| Procept Biorobotics Corporation | $14.14 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $13.64 | 2020 | |
| Abbott Laboratories | $12.42 | 2021 | |
| Thd America, INC. | $9.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.